Efficient resolution of Pneumocystis murina infection in surfactant protein A-deficient mice following withdrawal of corticosteroid-induced immunosuppression

被引:11
作者
Linke, M
Ashbaugh, A
Koch, J
Tanaka, R
Walzer, P
机构
[1] Dept Vet Afairs Med Ctr, Res Serv, Cincinnati, OH 45220 USA
[2] Univ Cincinnati, Coll Med, Dept Internal Med, Div Infect Dis, Cincinnati, OH 45221 USA
关键词
D O I
10.1099/jmm.0.46190-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Following withdrawal of immunosuppression, surfactant protein A (SP-A)-deficient and wild-type mice cleared Pneumocystis murina infection in a similar manner, but exhibited significant differences in lymphocyte populations, interleukin (IL)-6 levels and chemokine expression levels. A higher percentage of lymphocytes were detected in lung lavage fluid from SP-A-deficient mice, but more CD4+ T cells were isolated from lung tissue of wild-type mice. Higher concentrations of IL-6 were detected in lavage fluid and enhanced expression of lymphotactin and RANTES were detected in the lungs of wild-type mice. Equal levels of surfactant protein D were detected in SP-A-deficient and wild-type mice and no differences were detected in markers IF of lung injury between the two strains of mice. Thus, SP-A does not enhance organism clearance, but does modulate the host immune response during resolution of P. murina infection.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 27 条
[1]   Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice:: Attenuation of cytokine responses and reactive oxygen-nitrogen species [J].
Atochina, EN ;
Beck, JM ;
Preston, AM ;
Haczku, A ;
Tomer, Y ;
Scanlon, ST ;
Fusaro, T ;
Casey, J ;
Hawgood, S ;
Gow, AJ ;
Beers, MF .
INFECTION AND IMMUNITY, 2004, 72 (10) :6002-6011
[2]  
Barry S M, 2002, HIV Med, V3, P207, DOI 10.1046/j.1468-1293.2002.00115.x
[3]   A 4TH-ORDER NONLINEAR ITERATIVE METHOD IN BANACH-SPACES [J].
CHEN, D ;
ARGYROS, IK .
APPLIED MATHEMATICS LETTERS, 1993, 6 (04) :97-98
[4]   Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A [J].
Elhalwagi, BM ;
Zhang, M ;
Ikegami, M ;
Iwamoto, HS ;
Morris, RE ;
Miller, ML ;
Dienger, K ;
McCormack, FX .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 21 (03) :380-387
[5]   Surfactant protein a modulates the inflammatory response in macrophages during tuberculosis [J].
Gold, JA ;
Hoshino, Y ;
Tanaka, N ;
Rom, WN ;
Raju, B ;
Condos, R ;
Weiden, MD .
INFECTION AND IMMUNITY, 2004, 72 (02) :645-650
[6]   Surfactant protein A (SP-A) gene targeted mice [J].
Korfhagen, TR ;
LeVine, AM ;
Whitsett, JA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1408 (2-3) :296-302
[7]   Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection [J].
Koval, CE ;
Gigliotti, F ;
Nevins, D ;
Demeter, LM .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) :491-493
[8]  
LeVine AM, 1997, J IMMUNOL, V158, P4336
[9]   Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection [J].
LeVine, AM ;
Kurak, KE ;
Bruno, MD ;
Stark, JM ;
Whitsett, JA ;
Korfhagen, TR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (04) :700-708
[10]   Surfactant protein-A enhances respiratory syncytial virus clearance in vivo [J].
LeVine, AM ;
Gwozdz, J ;
Stark, J ;
Bruno, M ;
Whitsett, J ;
Korfhagen, T .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (07) :1015-1021